Is a Correction Looming Ahead for Acasti Pharma Inc. (ACST) – News Heater
Home  »  Hot Stocks   »  Is a Correction Looming Ahead for Acasti Pharma In...

Is a Correction Looming Ahead for Acasti Pharma Inc. (ACST)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Acasti Pharma Inc. (NASDAQ:ACST) went down by -3.02% from its latest closing price compared to the recent 1-year high of $1.22. The company’s stock price has collected -2.65% of loss in the last five trading sessions. Press Release reported on 07/23/21 that Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

>> 7 Top Picks for the Post-Pandemic Economy <<

Is It Worth Investing in Acasti Pharma Inc. (NASDAQ :ACST) Right Now?

Opinions of the stock are interesting as 0 analysts out of 1 who provided ratings for Acasti Pharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $0.25. ACST currently public float of 202.93M and currently shorts hold a 1.55% ratio of that float. Today, the average trading volume of ACST was 13.81M shares.

ACST’s Market Performance

ACST stocks went down by -2.65% for the week, with a monthly drop of -20.52% and a quarterly performance of -12.74%, while its annual performance rate touched -30.99%. The volatility ratio for the week stands at 5.74% while the volatility levels for the past 30 days are set at 7.13% for Acasti Pharma Inc.. The simple moving average for the period of the last 20 days is -13.77% for ACST stocks with a simple moving average of -6.59% for the last 200 days.

Analysts’ Opinion of ACST

B. Riley FBR, on the other hand, stated in their research note that they expect to see ACST reach a price target of $2. The rating they have provided for ACST stocks is “Buy” according to the report published on July 06th, 2020.

ACST Trading at -12.31% from the 50-Day Moving Average

After a stumble in the market that brought ACST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.10% of loss for the given period.

Volatility was left at 7.13%, however, over the last 30 days, the volatility rate increased by 5.74%, as shares sank -24.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.54% upper at present.

During the last 5 trading sessions, ACST fell by -2.65%, which changed the moving average for the period of 200-days by +129.25% in comparison to the 20-day moving average, which settled at $0.5289. In addition, Acasti Pharma Inc. saw 42.28% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for ACST

Current profitability levels for the company are sitting at:

  • -5532.14 for the present operating margin
  • -410.20 for the gross margin

The net margin for Acasti Pharma Inc. stands at -10039.80. The total capital return value is set at -31.48, while invested capital returns managed to touch -57.27.

Based on Acasti Pharma Inc. (ACST), the company’s capital structure generated 0.15 points at debt to equity in total, while total debt to capital is 0.15.

>> 7 Top Picks for the Post-Pandemic Economy <<

When we switch over and look at the enterprise to sales, we see a ratio of 56.56, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 0.36 and the total asset turnover is 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 39.50.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam